NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
A new Gilead study shows that a single-tablet combo of HIV-fighting drugs could help patients who today take multiple drugs.
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
A NEW, single-dose malaria treatment combining four existing drugs has been found to be as effective as the standard three-day regimen, offering a potential breakthrough against one of Africa’s ...
King’ongo Secondary School in Ubungo, Dar es Salaam, has received a newly constructed block of six modern toilets for both ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 million to buy shares. Novo Nordisk Stock Could Benefit From Eli Lilly’s ...
Which Political Leaders Cannot Be Trusted With Our Health By Carl E. Bartecchi, M.D. Robert F. Kennedy Jr., U.S. health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback